Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

Did a heart attack occur within one year of taking Premphase or Prempro?

Were any of the following problems experienced during or after taking HRT medication?

If you suffered any of the above conditions, what was your age when diagnosed?

What was the date you were diagnosed with TTP?

Please describe diagnosis:

Please describe history of HRT drug prescriptions (please provide date and drug used in chronological order):

If diagnosed with breast cancer, please indicate details of diagnosis:

Have any family members (sisters, mother, grandmothers) been diagnosed with breast cancer?

If yes, please describe which family member was diagnosed and the type of cancer that was diagnosed:

Have you been genetically screened for breast cancer?

If you have been screened for breast cancer, please describe results:

Please describe history of blood clots and/or strokes:

Did you ever take Provera?

If yes, did you take Provera while taking Premphase or Premarin?

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Estrogen Plus Progestin Doubles Dementia Risk In Women 65 And Over, WHIMS Study Shows

May 29, 2003 | University at Buffalo Reporter

A national study involving 151 women from Western New York, conducted to assess the effect of hormone therapy on dementia and mild cognitive impairment, has shown that women 65 and over who take combined estrogen and progestin may double their risk of developing dementia.

The Women's Health Initiative Memory Study (WHIMS) is a sub-study of the Women's Health Initiative (WHI). Jean Wactawski-Wende, assistant professor of social and preventive medicine and gynecology and obstetrics and co-director of UB's WHI Vanguard Center, is one of the study authors.

Results of the WHIMS study appear in this week's issue of the Journal of the American Medical Association.

"For postmenopausal women age 65 and over, estrogen plus progestin is not a viable option for prevention of cognitive impairment and, in fact, doubles the risk of developing dementia," said Wactawski-Wende. The WHIMS study included only women 65 and over, so the effect of hormone therapy on cognition in younger women hasn't been determined, she said.

While the risk of dementia in the population at large is doubled, the risk to each individual woman is relatively small, said Wactawski-Wende. "For every 10,000 women 65 or over who took estrogen plus progestin, 45 women developed dementia per year, compared to 22 cases of dementia in those taking placebo. This represents an additional 23 cases of dementia per year in every 10,000 women treated."

Wactawski-Wende said women should discuss these finding with their health-care providers, adding that the results of this study should be considered in the overall balance of risks and benefits of estrogen plus progestin for each woman.

The study involved 4,532 postmenopausal women age 65 and over. The women were followed for 4.2 years at 39 WHI clinical centers around the U.S. Half the women took a daily dose of the drug Prempro, a combination of estrogen and progestin, and half took a placebo.

This arm of the WHI study was terminated in July 2002, along with the WHI study assessing the effect of hormone therapy on cardiovascular disease in postmenopausal women, when the risks were found to outweigh the benefits. The data from the memory study had not been analyzed fully at that time.

The WHIMS study arm involving women who are taking estrogen alone, without progestin, is ongoing. Results of that study will be available by 2005.

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo